Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 891 of 6351
-
Double biologic punch: new combo trial for ulcerative colitis
Disease control OngoingThe purpose of this study is to evaluate the efficacy and safety of JNJ-78934804 as compared to guselkumab and golimumab in participants with moderately to severely active ulcerative colitis who have had an inadequate initial response, loss of response, or intolerance to one or m…
Phase 2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Balloon in the womb may save babies with rare birth defect
Disease control Recruiting nowThis is a single site pilot trial to study the feasibility of Fetoscopic Endoluminal Tracheal Occlusion (FETO) therapy in the most severe group of fetuses with congenital diaphragmatic hernia (CDH) at Ann \& Robert H. Lurie Children's Hospital of Chicago (Lurie Children's). This …
Sponsor: Aimen F. Shaaban, MD • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Italian study tests smarter lung cancer screening: fewer scans, same Life-Saving power?
Diagnosis OngoingThis prospective randomized multicentered clinical study aims at implementing early diagnosis of lung cancer in high-risk heavy smokers in the Italian population. The main goal of the study is to develop a nationwide lung cancer prevention screening with high quality standard, si…
Sponsor: Ugo Pastorino • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
New drug combo aims to tame rare liver virus
Disease control OngoingThis is a phase 2 trial in which participants with chronic hepatitis D virus (HDV) infection will receive VIR-2218 and/or VIR-3434 and be assessed for safety, tolerability, and efficacy
Phase 2 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Could a common ED drug help fontan hearts? new trial aims to find out
Disease control Recruiting nowThe purpose of this study is to find out more about the effectiveness of Tadalafil in improving hemodynamic capabilities, endothelial function, and end-organ function in patients who have previously undergone a Fontan Palliation.
Phase 3 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New 20-Strain pneumonia vaccine shows promise for infants
Vaccine CompletedThe purpose of this study is to understand the safety and effects of a study vaccine (20vPnC) in infants and toddlers. This study is enrolling participants who are: * Born after at least 36 weeks of pregnancy and about 2 months of age at the time of entering the study * Have a …
Phase 3 • Sponsor: Pfizer • Aim: Vaccine
Last updated Jun 27, 2026 08:04 UTC
-
Could freezing chest nerves replace opioids after mastectomy?
Symptom relief By invitation onlyBreast cancer is the most common type of cancer in women. Removal of the breast, called "mastectomy", is performed either when there is cancer-or an increased risk of cancer-in the breast. This can result in a lot of pain during the months after surgery. Opioids-"narcotics"-are t…
Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
New combo aims to outperform chemo in tough lung cancers
Disease control OngoingThis study will assess the efficacy and safety of the combination of ceralasertib and durvalumab versus standard of care docetaxel in patients with locally advanced and metastatic NSCLC after progression on prior anti-PD-(L)1 therapy and platinum-based chemotherapy.
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New hope for Hard-to-Treat lung cancer: targeted drug combo enters human trials
Disease control Recruiting nowThis study was an open, multicenter, dose-increasing/investigational Phase IB/II clinical trial to evaluate the efficacy of SHR-A1811 in combination with other antitumor therapies in subjects with advanced non-small cell lung cancer with HER2 . It can be divided into two parts, P…
Phase 1/2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New drug aims to cut steroid use in lung sarcoidosis
Disease control CompletedThis is a multicenter, randomized, double-blind, placebo-controlled, study comparing the efficacy and safety of intravenous (IV) efzofitimod 3 mg/kg and 5 mg/kg versus placebo after 48 weeks of treatment. This study will enroll adults with histologically confirmed pulmonary sarco…
Phase 3 • Sponsor: aTyr Pharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New hope for Platinum-Resistant ovarian cancer: PLX038 trial launches
Disease control OngoingThis phase II trial tests whether pegylated SN-38 conjugate PLX038 (PLX038) works to shrink tumors in patients with ovarian, primary peritoneal, and fallopian tube cancers that has spread from where it first started (primary site) to other places in the body (metastatic). PLX038 …
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
One-Shot antibody shields kids from malaria in landmark trial
Disease control CompletedThe purpose of this study is to evaluate the safety and tolerability of one-time subcutaneous (SC) administration of monoclonal antibody (MAb) L9LS in healthy Kenyan children aged 5 months to 10 years, as well as the protective efficacy of one or two doses of L9LS against natural…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Eye implant could restore sight in advanced AMD
Disease control Recruiting nowThe objective of this study is to demonstrate the safety and effectiveness of the SING IMT (Smaller Incision New Generation Implantable Miniature Telescope) 3X implant in improving vision in patients with central vision impairment associated with end-stage Age-related Macular Deg…
Sponsor: VisionCare, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New combo therapy aims to wipe out CLL cells in untreated patients
Disease control Recruiting nowThis phase II trial tests whether acalabrutinib in combination with venetoclax or obinutuzumab works to shrink tumors in patients with treatment-naive chronic lymphocytic leukemia . Acalabrutinib is also an inhibitor that works in the body to block the activation of certain cells…
Phase 2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New shot could tame Flare-Ups in ulcerative colitis patients
Disease control OngoingThe purpose of this study is to evaluate the efficacy, including clinical remission of guselkumab subcutaneous (SC) induction compared to placebo in participants with moderately to severely active ulcerative colitis (UC).
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Heavy weights vs. light weights: which builds better bones?
Disease control CompletedOsteoporosis is a bone disease that can result in fractures, disability and an increased risk of premature death. Exercise is recommended for fall and fracture prevention, but health care professionals often recommend walking or lower intensity community exercise classes, which m…
Sponsor: University of Waterloo • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Which comes first? new study aims to optimize AML treatment sequence
Disease control Recruiting nowThis phase II study compares the order of treatment with ivosidenib or enasidenib and azacitidine plus venetoclax in treating older patients with acute myeloid leukemia with genetic changes in the IDH1 or IDH2 genes (IDH mutated). Ivosidenib is in a class of medications called is…
Phase 2 • Sponsor: Alice Mims • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Can a lab-made flu vaccine outperform the traditional egg-based shot?
Prevention CompletedThis randomized, active comparator trial will compare the clinical efficacy of recombinant influenza vaccine (RIV) to standard-dose egg-based inactivated influenza vaccine (SD IIV) among adults aged 18-64 years. The primary study hypothesis is that the clinical efficacy of RIV is…
Phase 4 • Sponsor: Centers for Disease Control and Prevention • Aim: Prevention
Last updated Aug 01, 2026 00:00 UTC
-
New vaccine aims to stop deadly salmonella strains
Vaccine CompletedThe purpose of this study is to assess the safety, reactogenicity, and immune response induced by the GlaxoSmithKline Biologicals SA (GSK) Vaccines Institute for Global Health (GVGH) invasive nontyphoidal Salmonella-typhoid conjugate (iNTS-TCV) candidate vaccine to be administere…
Phase 1/2 • Sponsor: GlaxoSmithKline • Aim: Vaccine
Last updated Jun 27, 2026 08:00 UTC
-
Promising drug cocktail aims to stop breast cancer recurrence
Disease control Recruiting nowThis is an open label, multicenter, single arm phase II study to evaluate the efficacy and safety of ribociclib and ET in patients with locoregional recurrence of HR-positive, HER2-negative breast cancer.
Phase 2 • Sponsor: Oana Danciu • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC